Global Enteral Feeding Formulas Industry

Global Enteral Feeding Formulas Industry

  • September 2020 •
  • 379 pages •
  • Report ID: 5798511 •
  • Format: PDF
Global Enteral Feeding Formulas Market to Reach $8.4 Billion by 2027

Amid the COVID-19 crisis, the global market for Enteral Feeding Formulas estimated at US$5.4 Billion in the year 2020, is projected to reach a revised size of US$8.4 Billion by 2027, growing at aCAGR of 6.4% over the period 2020-2027. Standard Formula, one of the segments analyzed in the report, is projected to record 6.9% CAGR and reach US$5.4 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Disease-Specific Formulas segment is readjusted to a revised 5.5% CAGR for the next 7-year period.

The U.S. Market is Estimated at $1.5 Billion, While China is Forecast to Grow at 9.8% CAGR

The Enteral Feeding Formulas market in the U.S. is estimated at US$1.5 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.8 Billion by the year 2027 trailing a CAGR of 9.8% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.5% and 5.7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.1% CAGR.We bring years of research experience to this 5th edition of our report. The 379-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,
  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Danone SA
  • Fresenius Kabi AG
  • Global Health Products, Inc.
  • Hormel Foods Corporation
  • Mead Johnson Nutrition Company
  • Meiji Holdings Co., Ltd.
  • Nestec, Inc.
  • Victus, Inc.